pubmed-article:15491241 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0029921 | lld:lifeskim |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0205487 | lld:lifeskim |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0004271 | lld:lifeskim |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0233820 | lld:lifeskim |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:15491241 | lifeskim:mentions | umls-concept:C0439828 | lld:lifeskim |
pubmed-article:15491241 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:15491241 | pubmed:dateCreated | 2004-10-19 | lld:pubmed |
pubmed-article:15491241 | pubmed:abstractText | Attitude toward medications is important for medication adherence. A patient's drug attitude probably reflects a weighing of benefits against experienced or anticipated side effects or risks associated with the medication. We predicted (1) that drug attitudes would be more positive among schizophrenia patients taking second-generation compared to first-generation antipsychotics because of their greater tolerability and efficacy; and (2) that greater insight into illness, fewer extrapyramidal symptoms, and better social functioning would be associated with better attitudes toward psychiatric medication. | lld:pubmed |
pubmed-article:15491241 | pubmed:language | eng | lld:pubmed |
pubmed-article:15491241 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15491241 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15491241 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15491241 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15491241 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15491241 | pubmed:month | Oct | lld:pubmed |
pubmed-article:15491241 | pubmed:issn | 0160-6689 | lld:pubmed |
pubmed-article:15491241 | pubmed:author | pubmed-author:HendersonDavi... | lld:pubmed |
pubmed-article:15491241 | pubmed:author | pubmed-author:GoffDonald... | lld:pubmed |
pubmed-article:15491241 | pubmed:author | pubmed-author:EvinsA EdenAE | lld:pubmed |
pubmed-article:15491241 | pubmed:author | pubmed-author:FreudenreichO... | lld:pubmed |
pubmed-article:15491241 | pubmed:author | pubmed-author:CatherCorinne... | lld:pubmed |
pubmed-article:15491241 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15491241 | pubmed:volume | 65 | lld:pubmed |
pubmed-article:15491241 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15491241 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15491241 | pubmed:pagination | 1372-6 | lld:pubmed |
pubmed-article:15491241 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:meshHeading | pubmed-meshheading:15491241... | lld:pubmed |
pubmed-article:15491241 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15491241 | pubmed:articleTitle | Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. | lld:pubmed |
pubmed-article:15491241 | pubmed:affiliation | MGH Schizophrenia Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA. ofreud@massmed.org | lld:pubmed |
pubmed-article:15491241 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15491241 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15491241 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15491241 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15491241 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15491241 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15491241 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15491241 | lld:pubmed |